Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK4 | O96013 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.41 |
| ▸ | FCER2 | P06734 | 1/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TLK2 | Q86UE8 | 4/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6981475 | 1.00 | PAK4 (0.42) | PAK4CYP3A4CYP2C9BACE1FCER2 | |
| SCHEMBL6980872 | 0.92 | PAK4 (0.43) | PAK4BACE1GSK3BTP53MAPT | |
| SCHEMBL7982075 | 0.92 | PAK4 (0.43) | PAK4BACE1GSK3BTP53MAPT | |
| SCHEMBL7233945 | 0.89 | TP53 (0.43) | PAK4CYP3A4CYP2C9BACE1FCER2 | |
| SCHEMBL7233951 | 0.89 | TP53 (0.43) | PAK4CYP3A4CYP2C9BACE1FCER2 | |
| SCHEMBL6982535 | 0.88 | ROCK2 (0.43) | PAK4CYP3A4CYP2C9BACE1GSK3B | |
| SCHEMBL6982529 | 0.88 | ROCK2 (0.43) | PAK4CYP3A4CYP2C9BACE1GSK3B | |
| SCHEMBL6327561 | 0.87 | KMT2A (0.43) | SMN1; SMN2POLBKMT2A | |
| SCHEMBL6326726 | 0.87 | KMT2A (0.43) | SMN1; SMN2POLBKMT2A | |
| SCHEMBL6977152 | 0.87 | ACHE (0.43) | PAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1071665-B1 | SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-10-01 | — | — | EP | disclosed |